BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2021 9:22:19 AM | Browse: 444 | Download: 764
 |
Received |
|
2021-02-08 12:13 |
|
Peer-Review Started |
|
2021-02-08 12:22 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-04 17:25 |
|
Revised |
|
2021-04-13 09:41 |
|
Second Decision |
|
2021-05-06 14:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-06 14:28 |
|
Articles in Press |
|
2021-05-06 14:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-09 22:16 |
|
Typeset the Manuscript |
|
2021-05-29 04:41 |
|
Publish the Manuscript Online |
|
2021-06-11 09:22 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Low symptomatic COVID-19 in the elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Stanisław Łącki, Kinga Wyżgolik, Michał Nicze, Sylwia Georgiew-Nadziakiewicz, Jerzy Chudek and Kamil Wdowiak |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stanisław Łącki, N/A, N/A, N/A, Department of Internal Diseases and Oncological Chemotherapy, Medical University of Silesia, Reymonta 8, Katowice 40-027, Silesian Voivodeship, Poland. s.lacki@outlook.com |
| Key Words |
COVID-19; SARS-Co-V-2; Follicular lymphoma; Rituximab; Case report |
| Core Tip |
Follicular lymphoma (FL) is an indolent lymphoma requiring immunochemotherapy with rituximab. This anti-CD20 monoclonal antibody causes rapid and prolonged depletion of both malignant and normal B-cells, resulting in a significantly increased risk of infectious complications, including the novel coronavirus (severe acute respiratory syndrome coronavirus 2) infections (coronavirus disease 2019, COVID-19). We present here the first case of a mildly manifested COVID-19 in the elderly patient during ongoing FL treatment, without significant deterioration after rituximab administration. This case highlights that rituximab-based therapy may have no evident negative effect on the clinical course of COVID-19 in the patients with FL, which may be significant during the current pandemic. |
| Publish Date |
2021-06-11 09:22 |
| Citation |
Łącki S, Wyżgolik K, Nicze M, Georgiew-Nadziakiewicz S, Chudek J, Wdowiak K. Low symptomatic COVID-19 in the elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report. World J Clin Cases 2021; 9(18): 4859-4865 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i18/4859.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i18.4859 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
